In 2014, Stella joined Purdue Pharma as Executive Director, Managed Markets. She successfully re-shaped Managed Markets; infusing a new payer strategy and contracting analytics around profitable access. Her scope of responsibilities includes Commercial, Pharmacy, Government and Institutional channels.

At Blackstone Private Entity, Catalent, Stella accelerated revenue growth and helped the company file an IPO in early 2014. She developed and implemented highly successful marketing programs to launch 9 products, build 2 Joint Ventures and led acquisitions in globally.

At Merck, she lead the new commercial strategy efforts as a Leader in US Strategy Office, focusing on customer centricity, integration of Schering Plough and other critical M&A activities. As part of Merck, and Schering-Plough Joint Venture, she launched  multiple brands, re-engineered sales structures  and built managed care organizations to improve profitable access, drive product launch efficiency and create patient awareness of product benefits.

Stella holds a B.A. in Biology & Anthropology, a Pharmacy Degree from Temple University (Specializing in Oncology/Pain Mgmt) and a M.B.A. from LaSalle University. She is certified in Six Sigma (Green Belt), Lean Sigma and Organizational Change Management.